Apellis Pharmaceuticals
APLS
£14.34
Share price
-1.86%
Change (1 day)
-65.31%
Change (1 year)
Categories
Revenue for Apellis Pharmaceuticals (APLS)
Revenue in 2024 (TTM): £0.61 Billion
According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is £0.59 Billion. an increase over the revenue in the year 2023 that were of £0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Apellis Pharmaceuticals from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | £0.62 B | 100.02% |
| 2023 | £0.31 B | 399.33% |
| 2022 | £62.34 M | 26.43% |
| 2021 | £49.31 M | -73.18% |
| 2020 | £0.18 B | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |